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Summary Mechanical ventilation (MV) in chronic situations is commonly used, either
delivered invasively or by means of non-invasive interfaces, to control hypoventila-
tion in patients with chest wall, neuromuscular or obstructive lung diseases (either
in adulthood or childhood). The global prevalence of ventilator-assisted individuals
(VAI) in Europe ranges from 2 to 30 per 100 000 population according to different
countries.
Nutrition is a common problem to face with in patients with chronic respiratory
diseases: nonetheless, it is a key component in the long-term management of
underweight COPD patients whose muscular disfunction may rapidly turn to
peripheral muscle waste. Since long-term mechanical ventilation (LTMV) is usually
prescribed in end-stage respiratory diseases with poor nutritional status, nutrition
and dietary intake related problems need to be carefully assessed and corrected in
these patients.
This paper aims to review the most recent innovations in the field of nutritional
status and food intake-related problems of VAI (both in adulthood and in childhood).
& 2003 Elsevier Ltd. All rights reserved.
Long-term mechanical ventilation
Mechanical ventilation is used to augment or take
over an individual’s spontaneous respiration. This
intervention may be required to address acute
oxygenation difficulties or compensate for ventila-
tory pump failure. Mechanical ventilation is usually
continued until the acute lung injury and/or pump
failure recovers. Less commonly mechanical venti-
lation is used as a treatment in its own right to
control chronic hypoventilation in patients with
chest wall, neuromuscular or obstructive lung
disease (see Table 1).
Most recent data suggest that the global pre-
valence of ventilator-assisted individuals (VAI) in
Europe ranges from 2 to 30 per 100 000 population
according to different countries.1,2 Long-term
mechanical ventilation (LTMV) may be used con-
tinuously or for shorter periods e.g. during sleep.
Artificial ventilation is achieved by delivering
positive pressure to the airway (either invasively
via tracheotomy, or non-invasively via nasal/oral
interface) or applying negative pressure to the
chest wall.
The predominant mode is now nasal intermittent
positive pressure ventilation (NIPPV) which is
superceding tracheostomy intermittent positive
pressure ventilation (T-IPPV) in most cases where
bulbar reflexes are intact and ventilatory depen-
dence is not complete.3 The widespread applica-
tion of NIPPV has been made possible by
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improvements in ventilators’ technology and mask
design. Pioneering use of NIPPV in Duchenne
muscular dystrophy (DMD)4 has been followed by
work in other restrictive groups,5 and more
recently also in patients with chronic obstructive
pulmonary disease (COPD), although with less level
of evidence.6,7
Nasal, oral and full face mask interfaces are
available; nasal plugs which sit in the nares are
useful alternatives. In addition to commercial
masks, customised interfaces can be individually
constructed and are favoured by some centres.8
Intermittent positive pressure ventilation via
mouthpiece is used only in some centres in the
USA and France; its most well-documented role is
in patients with post-polio respiratory muscle
weakness.9 Mouthpieces may be purchased com-
mercially or custom-made; they can cause ortho-
dontic deformity and are therefore unsuitable in
children.
A wide range of ventilators has been designed for
primarily domiciliary use.8 These may offer advan-
tages in terms of performance over ventilators
intended for intensive care application and are
more easy to use in the home. They are mainly
classified into volume pre-set and pressure pre-set
devices or, according to the way to assist patient,
into assist, assist-control or control modes; in the
last 5–10 years pressure pre-set machines, particu-
larly bi-level pressure support equipment has
become more prominent.8
Since the 1960s LTMV through tracheostomy has
been an option in the management of subjects
suffering from chronic respiratory insufficiency in
stabilised neuromuscular disorders, kyphoscoliosis
or other restrictive conditions, central hypoventi-
lation and COPD.10 Usually, in the latter cases, the
choice of mechanical ventilation is long-term: to
reduce episodes of acute respiratory failure caused
by the progression of the disease, to enhance the
quality of life and to improve survival. Prolonged
invasive ventilatory life support is mandatory for
patients completely unable to breathe on their
own: this is the condition of the subject defined as
unweanable. Typically, these patients have high
level quadriplegia, but we can also include the
advanced steps of progressive neurological disor-
ders (i.e. amiotrophic lateral sclerosis).
Some patients who develop ventilatory failure
may start with NIPPV and then progress to T-IPPV as
bulbar weakness and increased ventilatory depen-
dence occur. Clearly a careful evaluation of
swallowing function, ability to cough, and ventila-
tory capacity are essential. The timing of the
initiation of ventilatory support is important: there
is no evidence to suggest that prophylactic NIPPV is
beneficial before the development of hypercapnia,
and it may even be detrimental in causing a delay
in seeking medical advice during acute exacerba-
tions.
Intermittent negative pressure ventilation (INPV)
is less commonly used in progressive neuromuscular
diseases;11 it may provoke or exacerbate upper
airway collapse. Advantages and contraindications
of INPV are shown in Table 2. Nevertheless when
treating patients with INPV several limitations
should be considered: (i) the lack of upper airway
protection, especially in unconscious and/or neu-
rological patients may result in aspiration, given
the reported effect of INPV on the lower oesopha-
geal sphincter,12 an effect to be prevented by pre-
medication with metoclopramide;(ii) upper airway
obstruction may occur13 or be enhanced in uncon-
scious patients, in patients with neurological
disorders with bulbar dysfunction and in those with
sleep apnoea syndrome. However, it has been
reported14 that in unconscious patients with normal
bulbar function, the placement of a naso-gastric
tube and the positioning of an oro-pharyngeal
airway can minimise the risk of aspiration and/or
airway collapsibility.
Long-term mechanical ventilation has been pro-
posed in addition to long-term oxygen therapy
(LTOT)15 in chronically hypercapnic COPD patients
with the theoretical rationale: to improve gas
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Table 1 Aims of mechanical ventilation.
The goals of mechanical ventilation are to:
* Control respiratory acidosis
* Improve gas exchange
* Reduce or take over the work of breathing
* Reverse atelectasis
* Reduce cardiac workload
* Minimise the complications related to
ventilatory support
Table 2 Side effects reported with INPV.
* Tiredness
* Depression
* Musculo-skeletal pain or tightness
* Oesophagitis
* Rib fractures and pneumothorax
* Impaired sleep quality
* Upper airway obstruction
* Poor compliance
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exchange;16 to unload the ventilatory muscles;16–18
to reset the central respiratory drive.19 Physiologi-
cal studies have shown that non-invasive mechan-
ical ventilation may unload the diaphragm in stable
COPD16–18 while some clinical studies suggested
that non-invasive nocturnal ventilation could be
associated with day-time arterial blood gas im-
provement, reduced hospitalisation and need of
tracheotomy.6,20,21
While NIPPV has been gaining increasing popu-
larity in the management of chronic respiratory
failure resulting from neuromuscular and restric-
tive chest wall diseases,5,7 controlled trials in
stable COPD patients reported conflicting results
on short-term, clinical and functional outcome.22–
25 Even fewer data are reported on the long-term
effects.6,19,21 More recently, a 2-year multicentre
controlled and randomised study has shown that
the addition of nocturnal NIPPV to usual oxygen in
hypercapnic COPD patients may result in better
outcomes (stabilisation of PaCO2 decrease of
chronic dyspnoea, improvement in quality of life
and reduction in ICU admissions) as compared with
patients continuing on LTOT alone.26
Nutrition
Size of the problem
A compromised nutrition has been associated with a
poor prognosis in stable COPD patients with and
without respiratory failure.27–29 Nutritional status
has been recently studied in 744 patients on long-
term respiratory treatments (LTOT or LTMV);30
authors have found that fat-free mass (FFM), body
mass index (BMI) below 20 and low serum albumin
were the most sensitive parameters detecting
malnutrition. Indeed, FFM appeared to be the most
sensitive and relevant nutritional parameter ac-
cording to patient’s impairment and disability as
assessed by FEV1 and 6-min walked distance.
30
Therefore, nutritional assessment and manage-
ment is an important therapeutic option in patients
with chronic respiratory diseases31 also when deal-
ing with prolonged/difficult weaning from mechan-
ical ventilation.32 In the study by Sivasothy et al.,33
chronically ventilated hypercapnic COPD patients
with body mass index (BMI) value lower than 20
showed a worse survival. Since 1990, only 19 (56%)
out of 37 papers on LTMV (Source MEDLINE, Key
words: LTMVþNutrition, excluding ventilatory
support due to sleep apnoea), reported BMI of
the studied patients. Long-term mechanical venti-
lation is usually prescribed in patients with end-
stage respiratory disease. Indeed in all 19 studies
mean BMI was lower than 25, being more compro-
mised in COPD than in restrictive thoracic
diseases.21,23–25,34,35 In chronically ventilated pa-
tients with cystic fibrosis BMI was lower than 20.36
Especially in COPD patients, respiratory muscle
dysfunction may be due also to conditions other
than impaired nutrition and/or metabolism (e.g.
hyperinflation, change in diaphragm configura-
tion).37 Indeed an impaired nutritional status
associated with respiratory muscle dysfunction
was described in six out of 37 papers (three in
COPD and three in restrictive thoracic dis-
eases).21,33,34,38–40
Table 3 emphasises the effects of malnutrition in
patients with respiratory diseases. Nevertheless,
specific nutritional deficiency like hypophosphate-
mia, can also have consequences on respiratory
function, otherwise causing acute respiratory fail-
ure.41 Moreover, abnormally high lipid synthesis
from glucose and decreased triglyceride mobilisa-
tion, due to the lack of physical exercise, may
contribute to an increase in the fat mass of
patients.42
Assessment and solutions
In the last decade, nutritional screening and
therapy has been considered as an essential
component in the long-term management of
pulmonary rehabilitation dealing, in particular,
with systemic manifestations such as weight loss,
muscle wasting and altered muscle metabolism
which are typical in advanced stages of COPD
patients.
The association between underweight per se and
increased mortality risk has been well established
in numerous retrospective studies ranging
from selected COPD patients to population-based
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Table 3 Adverse effects of malnutrition on thor-
aco-pulmonary functions.
* Altered ventilatory drive
* Reduction in the ventilatory response to hypoxia
* Decreased mass, force, contractility and
endurace of the diaphragm
* Decreased respiratory muscle strength
* Hypercapnia
* Reduced synthesis of alveolar surfactant
* Altered humoral and cellular immunity
* Increased bacterial adhesion in the lower
respiratory tract
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samples.27,43,44 Two prospective studies even
showed in COPD patients with a BMIo25 kg/m2
that weight gain was associated with decreased
mortality risk.27,45 Therefore, it can be concluded
that not only underweight COPD should be con-
sidered for caloric supplementation but also pa-
tients with a BMIo25 kg/m2 and involuntary weight
loss. This implies that COPD patients who suffer
from weight loss, and even weight stable patients
at risk, should be encouraged to increase their
apparently normal energy intake.
Treatment of weight loss may be achieved by
increasing dietary intake or preventing weight loss
by means of protein synthesis stimulation. How-
ever, in the home setting it is more difficult for
patients to balance their energy expenditure.
When oral nutritional supplements are consid-
ered, it is important to realise that there are
limitations to the caloric amount of supplements
that can be given daily; also the portion size and
distribution of supplements during the day is
important to consider.46 Substrate oxidation and
ventilation are intrinsically related and theoreti-
cally meal related dyspnoea and impaired ventila-
tory reserves might restrict the carbohydrate
content of nutritional support in respiratory dis-
ease. Earlier studies indeed showed adverse effects
of a carbohydrate-rich energy overload (970 kcal)47
but not using a normal energy load (500 kcal) 48 on
carbon dioxide production. Recent studies show
that carbohydrate-rich supplements may even have
positive effects. A fat-rich supplement, but not an
equicaloric carbohydrate-rich supplement, has
been shown to cause an acute increase in
dyspnoea.46
Sometimes increasing energy intake among se-
vere COPD cases is difficult to accomplish. There-
fore, interventions should also be extended to
prevention and early treatment of weight loss, that
is, before patients are extremely wasted. This
means expanding the target group to include
primary care patients before they have become
underweight, and putting more emphasis on
dietary change than on medically prescribed
supplementation.
From a nutritional point of view, wasting of
muscle mass is due to an impaired balance between
protein synthesis (anabolism) and protein break-
down (catabolism). However, other non-nutritive
factors including physical inactivity (which is quite
a typical attitude in patients undergoing LTMV),
alterations in the neuro-endocrine response and
presence of a systemic inflammatory response may
contribute to a negative protein balance. Several
studies have therefore investigated in underweight
COPD patients the effects of pharmacological
anabolic stimuli to promote protein synthesis
including anabolic steroids and growth hormone.
These studies were indeed able to document a
significant gain in muscle mass after intervention49
illustrating that there is room for specific stimula-
tion of protein synthesis in these patients. This may
also be achieved by increasing protein intake and
optimisation of essential amino acid intake. It has
been clearly shown in other wasting conditions that
adequate intake of protein is also a prerequisite for
optimal efficacy of anabolic drugs.50 Of interest are
the consistently reduced plasma levels of branched
chain amino acids (BCAAs) in underweight COPD
patients and in those with low muscle mass.51,52
Leucine is an interesting nutritional substrate since
it serves as precursor and enhances activity and
synthesis of proteins in skeletal muscle.53 Current
insight into the molecular mechanisms of cachexia
indicates a complex interaction between inflam-
matory mediators, oxidative stress and growth
factors involved in processes that govern skeletal
muscle fibre degeneration, apoptosis and regenera-
tion.54 At present from a nutritional and metabolic
perspective, specific interest has recently been
focused on fatty acid modulation, like the n-3
polyunsaturated fatty acids (PUFA), since fatty acid
composition of inflammatory and immune cells is
sensitive to change according to the fatty acid
composition of the diet. Fish oil (containing PUFA)
supplementation has beneficial effects on the
systemic inflammatory response and disease activ-
ity in conditions as rheumatoid arthritis and
inflammatory bowel disease.51 Clearly more clinical
trials are required to investigate the potential role
of fatty acids enriched supplements in cachexia or
other chronic wasting conditions like advanced
COPD or chronic respiratory failure.
Food intake-related problems in LTMV
patients
Since the 1960s long-term T-IPPV has been per-
formed in neuromuscular disorders, kyphoscoliosis
or other restrictive conditions, central hypoventi-
lation and COPD.10 Prolonged invasive mechanical
ventilation is mandatory in patients completely
unable to breathe on their own55 and it is still
considered the gold standard against which other
more recent techniques are compared. Neverthe-
less, one of the most important problems occurring
in patients needing prolonged T-IPPV is swallowing
dysfunction. Although a swallowing dysfunction is
usually induced by an underlying neuromuscular
disease, many factors may contribute including:
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acute illness and medications used to treat these
conditions (steroids, neuromuscular blocking
agents, general sedatives), prolonged inactivity of
swallowing muscles, injury due to endotracheal
intubation, tracheostomy tube.56 Tracheostomy
per se has been described to limit swallowing
function by either compressing the oesophagus or
decreasing larynx elevation and anterior displace-
ment.57 When T-IPPV is used, an inflated tracheost-
omy tube cuff anchors the strap muscles in the
neck, hampering laryngeal elevation and neck
rotation. This results in reduced glottic closure
and increased laryngeal penetration, increasing the
chances of aspiration.58
Recent studies both in acute and chronic set-
ting58–60 suggested that swallowing dysfunction and
pulmonary aspiration occur in patients receiving
ventilatory support through a cuffed tracheostomy
tube. Nevertheless, the real incidence of aspiration
is difficult to determine, since investigators often
use different criteria for its presence.56,58 There-
fore, dietary intake through the mouth should be
carefully evaluated. Recognition of swallowing
dysfunction in these patients may identify patients
at high risk of aspiration, and thereby help to avoid
related complications such as recurrent pneumo-
nia61 and atelectasis. In a recent study60 of patients
receiving MV via artificial airways for more than 15
days, swallowing abnormality detected at bedside
examination was found in 34% of cases without any
significant difference according to the presence or
absence of an underlying neuromuscular disease. In
these patients, barium swallow with video-fluoro-
scopy (BS/VF) was abnormal in 83% of patients. In
50% of patients who underwent direct laryngoscopy
important abnormalities were found that contrib-
uted to swallowing dysfunction. Results of early
(o1 month) repeated BS/VF examination in pa-
tients were unchanged; however in a small group of
patients, later studies (41 month) revealed sig-
nificant improvement. These authors60 concluded
that patients requiring prolonged mechanical ven-
tilation present a high incidence of swallowing
abnormalities, regardless the presence or absence
of neuromuscular disorders; BS/VF and direct
laryngoscopy can provide useful information about
laryngeal action and swallowing, and can facilitate
the implementation of corrective actions (selected
food, head postures, coached cough reflex) to
prevent respiratory complications.
In a study by Schoenhofer et al.59 aspiration was
found in 16% of patients independent of whether
documented clinically on the basis of cough,
distress after swallowing, expectoration or suction-
ing at bronchoscopy of enteral nutrition or by
means of scintigraphic method after 99mTc-labelled
meal. Clinical assessment was able to discover
swallowing dysfunction in 6.5% of patients negative
to scintigraphy. On the other hand, scintigraphy
was positive in 6.5% of patients with negative
clinical assessment. Overall presence of swallowing
dysfunction was therefore found in 29% of these
patients with need of prolonged invasive MV.
Independent on the need of NIPPV or T-IPPV,
when dysphagia is present, VAI are commonly
referred to a multidisciplinary team (including
neurologist, nutritionist, gastro-enterologist) since
the decision for either corrective actions prevent-
ing respiratory complications (such as use of higher
consistency food or specific head postures)62,63 or
long-term enteral nutrition cannot be usually
delayed. Patient’s ventilatory insufficiency is rarely
recognised and treated before tachypnoea and
dyspnoea hamper swallowing efforts. Since weight
loss correlates with swallowing impairment,64 body
weight almost invariably increases once adequate
ventilatory assistance and dietary intake are
provided.65 The use of NIPPV facilitates swallowing
efforts, but the patients must be trained to
coordinate the assisted breathing with swallowing.
In general, non-invasive respiratory aid alterna-
tives to tracheostomy are effective until severe
bulbar muscle dysfunction results in ongoing aspira-
tion of food and saliva. When aspiration causes an
arterial oxygen desaturation below 95%, despite
optimal use of assisted ventilation and coughing
methods, bronchial mucus and food pooling may
result in episodes of pneumonia.64
Dysphagia-associated nutritional deficiencies are
very common but rarely diagnosed early, and their
management especially for patients with neuro-
muscular disorders is often considered to be of
secondary importance. The consequences can be
severe on locomotion and respiratory function as
well as on other bodily systems.
Percutaneous endoscopic gastrostomy (PEG) as a
measure of enteral tube feeding66 has gained wide
acceptance and it is, nowadays, the preferred
method for providing enteral nutrition in long-term
settings with the aim to prevent the most serious
complications. Short-term studies have demon-
strated the advantages of PEG as compared to the
naso-gastric tube feeding in patients with dyspha-
gia due to chronic neurological diseases.67,68 PEG
insertion is a quick procedure generally well
tolerated by patients and a relatively low compli-
cation rate in the outcome has been described. Hull
and coworkers69 showed that, in 49 consecutive
patients undergoing PEG insertion due to dyspha-
gia, 27 complications (site infections, mechanical
problems, gastrointestinal dysfunction) occurred
after 30 days or more, whereas 51% of patients had
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no problem at all. Reflux and aspiration are also
significantly reduced by PEG.70 For this reason PEG
is considered a good solution for an early discharge
home, leaving also the opportunity to be easily
removed in the case, if any, of reversibility or
improvement of dysphagia and it does not contra-
indicate oral feeding. In patients needing long-term
ventilatory support with impaired swallowing such
as in neurological diseases, PEG is often proposed.
It ensures an enhanced daily dietary intake toward
recovery and reduced major complication (i.e.
infections),71 and may be a bridge solution toward
oral feeding.
Nutrition and food intake-related
problems in children with LTMV
Nutritional problems are common in children with
chronic respiratory failure, particularly in infants
with chronic lung diseases72 leading to failure to
thrive and malnutrition. The effects of malnutrition
on respiratory function are well described in
animals and humans and include reduction of
respiratory muscle mass and reduced contractile
strength, leading to reductions in respiratory
muscle strength, endurance and vital capa-
city.27,28,31,73 These deleterious effects of malnu-
trition are generally reversible with nutritional
repletion. In children, a multitude of factors is
frequently responsible for this, including gastro-
oesophageal reflux, oromotor dysfunction, beha-
vioural feeding refusal. The importance of the
composition of feeding has been recognised for
sometime with diets high in carbohydrates leading
to excessive carbon dioxide production. This finding
has prompted many to provide up to 50% of non-
protein calories as fat.
The most important problems are described in
mechanically ventilated children with neuromus-
cular disease, many of whom have high caloric
requirements.74 Even normal caloric intakes based
on patient age and weight, may lead to obesity,
which will further embarass the patient respiratory
function and mobility. Attempts to limit caloric
intake may however inadvertently lead to exces-
sive protein mineral and oligoelements depletion in
children with chronic respiratory failure.
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